Combined ACTH and glucocorticoid treatment improves survival and organ maturation in premature newborn calves.
Glucocorticoids play an important role in prenatal organ maturation in many species. In humans, maternal treatment with synthetic glucocorticoids improves neonatal adaptation of prematurely born infants. In cows, pre-term calf survival is improved following a single maternal glucocorticoid administration. We hypothesized that stimulation of endogenous cortisol secretion by adrenocorticotropin (ACTH) treatment combined with maternal dexamethasone treatment, would be even more efficient in stimulating organ maturation in the prematurely delivered calf. Three groups of premature calves were delivered by caesarian section at 90% of gestation length from dams which were either untreated or injected with dexamethasone before delivery, combined with either prenatal or postnatal ACTH treatment to the calf. During the first 24h after birth, thermoregulation, blood chemistry, liver values and organ weights were recorded. In the untreated calves, survival was significantly correlated with blood oxygenation, sodium and calcium levels at the moment of birth. There were marked maturational effects of the treatments on body temperature regulation, blood acid-base status, oxygenation, glucose, insulin, IGF-1 levels, weight of the heart, liver, gastrointestinal tract and thymus weight. For many of the measured metabolic, endocrine and organ weight parameters, the intrauterine ACTH treatment was associated with improved values relative to the postnatal ACTH treatment, which appeared to have no immediate effect on calf viability. In conclusion, the premature calf delivered by caesarian section at 90% of gestation length showed blood chemistry, metabolic, endocrine and organ growth characteristics that indicated severe prematurity. However, the maturation of organ function in newborn premature calves following maternal glucocorticoid injections was further enhanced if is was preceded by intra-fetal injections of ACTH.
Schmidt
M
M
Department of Clinical Studies, Reproduction, Royal Veterinary and Agricultural University, Dyrlaegevej 68, DK-1870 Frederiksberg C, Denmark. mhs@kvl.dk
Sangild
P T
PT
Blum
J W
JW
Andersen
J B
JB
Greve
T
T
D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage*; D000818:Animals; D000831:Animals, Newborn / Q000502:physiology*; D001769:Blood; D001786:Blood Glucose / Q000032:analysis; D001831:Body Temperature; D002417:Cattle; D005260:Female; D005325:Fetal Organ Maturity / Q000187:drug effects*; D005865:Gestational Age; D005938:Glucocorticoids / Q000008:administration & dosage*; D006863:Hydrogen-Ion Concentration; D007334:Insulin-Like Growth Factor I / Q000032:analysis; D008099:Liver / Q000033:anatomy & histology; D008431:Maternal-Fetal Exchange; D009929:Organ Size / Q000187:drug effects; D011247:Pregnancy; D013997:Time Factors
D001786:Blood Glucose; D005938:Glucocorticoids; D007334:Insulin-Like Growth Factor I; D000324:Adrenocorticotropic Hormone